2016 ACR/ARHP Annual Meeting Archives - Page 148 of 219

Abstract Number: 510

C-Reactive Protein and Disease Activity in Rheumatoid Arthritis: Impact of Obesity and Adiposity
Abstract Number: 128

Call to Action: Cardiovascular Comorbidities in Medicare Rheumatology Beneficiaries
Abstract Number: 381

Calprotectin As a Multipotent Biomarker in Juvenile Idiopathic Arthritis
Abstract Number: 3037

Calprotectin Is Highly Upregulated in Inflamed Axial Entheses in SKG Mice
Abstract Number: 492

Calprotectin Levels Correlate with Inflammation in Early Rheumatoid Arthritis before Disease-Modifying Antirheumatic Drug Treatment and after 12 Months of Treatment
Abstract Number: 651

Calprotectin Serum Levels Strongly Predict Disease Flare in RA and Psa Patients with Low Disease Activity Treated with TNF Inhibitors. a One-Year Prospective Cohort Study
Abstract Number: 2740

Cam Type Femoroacetabular Impingement Morphology Is More Frequent in Patients with Axial Spondyloarthritis
Abstract Number: 3100

Can Achieving Sustained Minimal Disease Activity (MDA) Prevent Progression of Subclinical Atherosclerosis? a Prospective Cohort Study in Psoriatic Arthritis
Abstract Number: 681

Can Bridging Syndesmophytes Independantly Affect Spinal Mobility?
Abstract Number: 2223

Can Fibromyalgia be Empirically Defined By the Number of Pain Locations Plus Symptoms?
Abstract Number: 2640

Can GP88 (Progranulin) be Used to Predict the Efficacy of Infliximab?
Abstract Number: 1272

Can Histologically Defined Peri-Articular Vascular Channels be Identified on High-Resolution Computed Tomography? – a Study in Cadaveric Finger Joints
Abstract Number: 352

Can Lumbar Spine Bone Mineral Density Predict Readmission in Denosumab-Treated Chronic Kidney Disease Patients?
Abstract Number: 1885

Can Nailfold Videocapillaroscopy Images be Interpreted Reliably By Different Observers? Results of an Inter-Reader and Intra-Reader Exercise Among Rheumatologists with Different Experience in This Field
Abstract Number: 1133

Can Patient Videos in Lectures Increase Interest and Improve Learning in Rheumatology Among Second Year Medical Students?
Abstract Number: 1299

Can the 3D-Modified Dixon Methods Replace the Conventional Sacroiliac Joint Magnetic Resonance Imaging?
Abstract Number: 500

Can Thiol/Disulphide Is a Novel Marker in Rheumatoid Arthritis?
Abstract Number: 782

Can We Identify Who Benefits from Mycophenolate Mofetil in Systemic Lupus Erythematosus? a Systematic Review
Abstract Number: 1735

Canadian Humira Post-Marketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis (Complete-PsA): Interim Analysis
Abstract Number: 614

Canadian Study of Outcomes in Adalimumab (HUMIRA®) Patients with Support for Adherence – Results from the Companion Study
Abstract Number: 2381

Canakinumab Monotherapy for the Treatment of Majeed Syndrome. Five-Year Experience
Abstract Number: 2990

Cancer in Systemic Lupus Erythematosus: Results from the Systemic Lupus International Collaborating Clinics Inception Cohort
Abstract Number: 2327

Cardiac Involvement in Inflammatory Myopathies: A Report from the Remicam Registry
Abstract Number: 1792

Cardiac Surgery in Systemic Lupus Erythematosus Patients: Clinical Characteristics and Outcomes
Abstract Number: 2097

Cardiolipin-Producing Candidate Commensals in the Gut Microbiome of Antiphospholipid Syndrome Patients
Abstract Number: 2293

Cardiometabolic Risk and Subclinical Urate Deposits in Patients with Symptomatic Hyperuricemia and Metabolic Syndrome
Abstract Number: 830

Cardiopulmonary Disease Development in Anti-RNA Polymerase III Positive Systemic Sclerosis; Comparative Analyses from an Unselected, Prospective Patient Cohort
Abstract Number: 881

Cardiopulmonary Involvement in Takayasu Arteritis
Abstract Number: 3114

Cardiorespiratory Fitness in Children with Juvenile Idiopathic Arthritis Treated in the Biological Era Is Comparable with Controls- a Cross-Sectional Study
Abstract Number: 1479

Cardiovascular Diseases and Mortality Are Independently Influenced By Carotid Plaque Presence in Rheumatoid Arthritis: The 5-Year Prospective Study
Abstract Number: 423

Cardiovascular Risk and Lipid Screening in Rheumatoid Arthritis Patients in a University Rheumatology Practice: Quality Improvement Project
Abstract Number: 1466

Cardiovascular Risk Assessment in Persons with Rheumatoid Arthritis: A Correlative Study of Non-Invasive Arterial Health Testing with the Inflammatory Burden of Disease
Abstract Number: 1467

Cardiovascular Risk Assessment in Persons with Rheumatoid Arthritis: Non-Invasive Arterial Health Testing to Assess Subclinical Risk of Cardiovascular Disease
Abstract Number: 2170

Cardiovascular Risk in Patients with Psoriasis, Psoriatic and Rheumatoid Arthritis: A Prospective Study Using Secured Anonymised Information Technology Databank in Wales, United Kingdom
Abstract Number: 2611

Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis
Abstract Number: 3053

Cartilage Loss Primarily Occurs in the Most Affected Tibiofemoral Compartment with No Evidence of a Ceiling Effect Among Advanced-Stage Disease: A Two-Year Longitudinal Study of Data from the Osteoarthritis
Abstract Number: 1311

Causative Pathogens, Antibiotic Susceptibility, and Characteristics of Patients with Bacterial Septic Arthritis over Time
Abstract Number: 1246

Causes and Predictors of Early Readmission in Systemic Lupus Erythematosus
Abstract Number: 2437

Causes of Cesarean Section and Labor Induction in Systemic Lupus Erythematosus and Rheumatoid Arthritis Pregnancies
Abstract Number: 3052

Causes of Death for Patients with Rheumatoid Arthritis
Abstract Number: 472

CCR6 Expression Regulates Arthritis in a T Cell Dependent Manner
Abstract Number: 179

CD11b+Gr1dimcells, Which Are Induced By GM-CSF Produced By Th17 and Group3 Innate Lymphoid Cell, May Facilitate the Progression of Pneumonitis in SKG Mice
Abstract Number: 2136

CD14 Deficiency Delays Progression of Cartilage Degeneration and Protects Against Early Deficits in Functional Outcomes in a Murine Osteoarthritis Model
Abstract Number: 2874

CD16+monocytes Are Enriched and Functionally Exacerbated in Driving B Cell Activation Under Systemic Lupus Erythematosus Condition
Abstract Number: 1822

CD4+ T Cell Lymphopenia Is Associated with Deficient Ubiquitination of the Cell Cycle Inhibibitor p27kip1 By the E3 Ligase Casitas B-Lineage Lymphoma-b in Patients with Systemic Lupus Erythematosus
Abstract Number: 2882

CD4+ T Helper Cells and Regulatory T Cells in Active Lupus Nephritis – an Imbalance Towards a Predominant Th1 Response?
Abstract Number: 1075

CD40-Pathway Activation in Ectopic Lymphoid Structure (ELS)-Resident B Cells Contributes to Disease Pathology in Primary SjöGren’s Syndrome
Abstract Number: 2421

Cell-Bound Complement Activation Products Correlate with Disease Activity in Childhood-Onset Systemic Lupus Erythematosus
Abstract Number: 2800

Cell-Bound Complement Activation Products in Multi-Analyte Assay with Algorithm Aid the Diagnosis of Systemic Lupus Erythematosus
Abstract Number: 581

Cell-Mediated Neutrophil Lysis-a Mechanism Promoting Hypercitrullination in Rheumatoid Arthritis?
Abstract Number: 2884

Cell-Type Specific Epigenetic Features of Systemic Lupus Erythematosus
Abstract Number: 1197

Certain Serum Micro-RNAs Are Associated with Osteoarthritis
Abstract Number: 350

Change in Bone Mineral Density with High-Dose Prednisone in Patients with Rheumatoid Arthritis
Abstract Number: 2231

Change in Health Care Utilization after Etanercept Initiation in Patients with Rheumatoid Arthritis
Abstract Number: 2554

Changes in Blood Pressure Following the Initiation of Disease Modifying Therapies in US Veterans with Rheumatoid Arthritis
Abstract Number: 551

Changes in Diverse Disease Activity Measures Are Highly Correlated Following the Initiation of Most Treatment Modalities in the Management of Longstanding Rheumatoid Arthritis
Abstract Number: 353

Changes in Femoral Neck Bone Mineral Density Inverse Correlate with Egfr in Denosumab Treated Osteoporosis Patients? a Hospital-Based Analysis
Abstract Number: 2676

Changes in Salivary Gland Echostructure in Patients with Primary SjöGren’s Syndrome over the Time: A Four-Year Longitudinal Study
Abstract Number: 526

Changes in the Functional Status of the Rheumatoid Arthritis (RA) Population over the Biologic Era
Abstract Number: 2850

Changes in Urinary Biomarker Levels Can Predict Treatment Responses in Lupus Nephritis
Abstract Number: 542

Changes on Body Composition in Women with Long-Standing Established Rheumatoid Arthritis: Differences By Level of Disease Activity
Abstract Number: 3086

Changing Patterns over Time in Opiate Use in U.S. Rheumatoid Arthritis Patients
Abstract Number: 1918

Characterising the Specificity, Function and Behavior of CD4+ T Cells Initiating Inflammation in a Murine Model of Rheumatoid Arthritis
Abstract Number: 2753

Characteristic and Outcomes of Psoriatic Arthritis Patients with Hyperuricemia, Whether We Should Treat or Not?
Abstract Number: 1202

Characteristic Compositional and Functional Alteration of Gut Microbiota in Patients with Behcet’s Disease
Abstract Number: 1673

Characteristic Phenotypes of Peripheral T Cells and Efficacy of Biological Dmards in Patients with Psoriatic Arthritis
Abstract Number: 2971

Characteristics and Management of IgA Vasculitis (Henoch-Schönlein purpura) in Adults: Data from the 260 Patients Included in the Igavas Survey
Abstract Number: 2749

Characteristics of Ankylosing Spondylitis Patients with Primary and Secondary Lack of Efficacy to TNF-Inhibitor Treatments
Abstract Number: 554

Characteristics of Functional Impairment in Patients with Long-Standing Rheumatoid Arthritis Based on Range of Motion of Joints: Multicenter Prospective Cohort Study for Evaluation of Joint Surgery on Physical Function
Abstract Number: 1314

Characteristics of the Musculoskeletal Symptoms Observed Among Survivors of Ebola Virus Disease (EVD) in the Postebogui Cohort in Guinea
Abstract Number: 2688

Characteristics, Treatment and Outcome of Joint Involvement with Synovitis in Primary SjöGren’s Syndrome: French Multicentric Retrospective Case-Control Study
Abstract Number: 1344

Characteristics, Treatment and Outcome of Severe Pulmonary Hemorrhage Related to Systemic Disease: French Multicentric Study
Abstract Number: 281

Characterization of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies
Abstract Number: 3035

Characterization of DC-STAMP+ T Cells, a CD3+CD4+ T Cell Subset Uniquely Present in Patients with Psoriatic Disease
Abstract Number: 265

Characterization of Eye Sarcoidosis with or without Systemic Involvement: Application of Iwos Criteria in an Uveitis Unit
Abstract Number: 2431

Characterization of Innate Immune Cells in Patients with the Interferon-Mediated Autoinflammatory Diseases Sting Associated Vasculopathy with Onset in Infancy (SAVI) and Chronic Atypical Neutrophilic Dermatosis with Lipodystrophy and Elevated Temperature (CANDLE)
Abstract Number: 2255

Characterization of Low-Density Granulocytes in Autoinflammatory Disorders
Abstract Number: 237

Characterization of Peripheral Lymphocyte Phenotype in Patients with IgG4-Related Disease
Abstract Number: 1319

Chikungunya Fever in Patients on Biological and on Conventional Dmards Therapy – Results from the Brazilian Register Biobadabrasil
Abstract Number: 1320

Chikungunya Fever Outbreak in Brazil: Preliminary Assessment in a Cohort of Patients with Rheumatological Manifestations
Abstract Number: 2056

Choroid Plexus Infiltrates in Lupus Model (MRL/lpr) Mice Represent Tertiary Lymphoid Structures, Shedding Light on the Immunological Mechanisms of Neuropsychiatric Lupus
Abstract Number: 76

Chromatin Interactions Reveal Novel Gene Targets for Drug Repositioning in Rheumatic Diseases
Abstract Number: 1693

Chronic Back Pain in Early Psoriatic Arthritis
Abstract Number: 371

Chronic Pain in Children Seen at a Rheumatology Clinic: Healthcare Utilization Patterns
Abstract Number: 993

Chronic Widespread Pain Associated with Premature Mortality in a UK National Prospective Study
Abstract Number: 1774

Chronological Analysis of Damage Accrual in Patientes with Systemic Lupus Erythematosus: Results from the Spanish Registry of Patients with SLE of the Spanish Society of Rheumatology (RELESSER)
Abstract Number: 2988

Cigarette Smoking Increases the Risk of Anti-Double-Stranded DNA Positive SLE Among Women in the Nurses’ Health Studies
Abstract Number: 595

Cinical Responses and Improvements in Patient-Reported Outcomes Are Associated with Increased Productivity in the Workplace and at Home in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol
Abstract Number: 2839

Circulating CD4+CD28null T-Cells Predict the Occurrence of New Lung Damage in Systemic Lupus Erythematosus (SLE) Patients
Abstract Number: 939

Circulating IgG4 Antibody Secreting Cells Are Better Biomarker of Disease Activity Compared to Serum IgG4 Levels in Patients with IgG4-Related Disease
Abstract Number: 3108

Citrullinated Aggrecan Peptides Are Targets of Auto-Reactive CD4+ T-Cells in Rheumatoid Arthritis
Abstract Number: 3020

Citrullination of Inhibitor of DNA Binding-1 at Specific Locations Leads to Autoantigenicity in Rheumatoid Arthritis
Abstract Number: 1999

Claims-Based Analysis of Cost-Effectiveness Among Patients with Rheumatoid Arthritis Who Switched from a Tumor Necrosis Factor Inhibitor to Another Targeted Disease-Modifying Antirheumatic Drug
Abstract Number: 1180

Class V Lupus Nephritis Results in Significant Numbers of End Stage Renal Disease and Death in a Population-Based Registry
Abstract Number: 891

Clinal Characterisitics and Diagnosis of Patients with Negative Temporal Artery Biopsy and without a Final Diagnosis of Giant Cell Arteritis
Abstract Number: 620

Clinical Activity, Ultrasound Assessment and Drug Monitoring in Rheumatoid Arthritis Patients Receiving Anti-TNF-α Therapy with Extended Interval of Administration
Abstract Number: 1349

Clinical Analysis of Hypertrophic Pachymeningitis
Abstract Number: 347

Clinical Analysis of Tumor-Induced Osteomalacia Misdiagnosed As Spondyloarthritis: A Report of 18 Cases
Abstract Number: 627

Clinical and Immunogenicity Outcomes after Switching Treatment from Innovator Infliximab to Biosimilar Infliximab in Rheumatic Diseases in Daily Clinical Practice
Abstract Number: 2681

Clinical and Immunological Characteristics of Primary Sjogren´s Syndrome in Men
Abstract Number: 745

Clinical and Laboratory Correlates of Response in a Phase 3 Clinical Trial of Belimumab or Placebo Administered Subcutaneously Plus Standard Care to Patients with Systemic Lupus Erythematosus (SLE)
Abstract Number: 242

Clinical and Laboratory Features of IgG4-Related Retroperitoneal Fibrosis/Periarteritis in Japan: Retrospective Multicenter Study of 99 Cases
Abstract Number: 730

Clinical and Quality of Life Improvements Observed with Golimumab and Infliximab in a Large Real-Life Ankylosing Spondylitis Population
Abstract Number: 1633

Clinical and Radiographic Outcomes after 3 Years of Sarilumab in Patients with Rheumatoid Arthritis
Abstract Number: 2219

Clinical and Radiological Characteristics of Patients with Adhesive Capsulitis and Shoulder Impingement Syndrome
Abstract Number: 3209

Clinical and Radiological Outcomes of 5 Years Remission Steered Treatment in Early Rheumatoid and Undifferentiated Arthritis Patients
Abstract Number: 965

Clinical and Serologic Variables Associated with Renal Response Among Lupus Nephritis Phase III Trial Patients Treated with Standard of Care Immunosuppression
Abstract Number: 2400

Clinical and Treatment Factors Associated with Antibiotic-Refractory Lyme Arthritis in Children
Abstract Number: 3202

Clinical and Ultrasonographic Evaluation of Joint Involvement in Patients with Systemic Sclerosis
Abstract Number: 2934

Clinical Assessment of the Monoclonal Anitbody, PRX003, a Potential Novel Treatment for Th17-Mediated Inflammatory Disease
Abstract Number: 853

Clinical Associations of Anti-Eukaryotic Initiation Factor 2B (anti-eIF2B) Antibodies in a Large Cohort of Patients with Anti-Nuclear Antibody Negative Systemic Sclerosis
Abstract Number: 1936

Clinical Characteristics of Inflammatory Eye Disease in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Cohort Study
Abstract Number: 984

Clinical Characteristics of Inflammatory Myopathies Associated with Cancer: A Report from the Remicam Registry
Abstract Number: 2388

Clinical Characterization and Outcomes of Pediatric Chronic Nonbacterial Osteomyelitis
Abstract Number: 2146

Clinical Characterization of Itch in Dermatomyositis and the Role of Increased Skin Interleukin-31
Abstract Number: 973

Clinical Characterization of Patients with World Health Organization Group 2 Pulmonary Hypertension in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Cohort
Abstract Number: 1368

Clinical Course of Juvenile Dermatomyositis Presenting As Skin Predominant Disease
Abstract Number: 1357

Clinical Description of Patients with Cytoplasmic Discrete Speckles on Indirect Immunofluorescence on HEp-2 Cells in a Universitary Hospital
Abstract Number: 649

Clinical Evaluation Usefulness of Standardized Protocol Strategies of Dose Reduction in Patients with Rheumatoid Arthritis in Clinical Remission Treated with Biologic Therapies. the Optibio Study
Abstract Number: 3008

Clinical Factors Associated with Non-Response to Methotrexate in Children with Juvenile Idiopathic Arthritis: Results from the Childhood Arthritis Response to Treatment Consortium
Abstract Number: 1954

Clinical Features and Long Term Outcome of 105 Patients of Granulomatosis with Polyangiitis: A Single Centre Experience from North India
Abstract Number: 904

Clinical Features and Mortality of 411 Chinese Takayasu’s Arteritis Patients
Abstract Number: 1924

Clinical Features and Outcome in Patients with Elderly Onset ANCA Associated Vasculitis
Abstract Number: 1316

Clinical Features and Outcomes of Prosthetic Joint Septic Arthritis: The Gender Effect
Abstract Number: 1546

Clinical Features at the Onset of Lymphoproliferative Disorder in Patients with Rheumatoid Arthritis
Abstract Number: 901

Clinical Features of Takayasu’s Arteritis from an Inception Cohort: Early Disease Is Characterized By ‘systemic Inflammation’
Abstract Number: 2677

Clinical Features of Primary Sjogren’s Syndrome Associated Lung Involvement with Extro-Glandular Manifestations at Onset
Abstract Number: 1801

Clinical Implications of Persistent Sinus Tachycardia in Systemic Lupus Erythematous: A Retrospective Study
Abstract Number: 2887

Clinical Predictors for Development of Interstitial Lung Disease in Mixed Connective Tissue Disease
Abstract Number: 223

Clinical Predictors of Acute Gout Flares within Hospitalized Patients at a Tertiary Care Center in New York
Abstract Number: 3012

Clinical Predictors of TNF-Inhibitor Free Disease Control in Patients with Rheumatoid Arthritis after Stopping TNFi Treatment: Results from a Dutch Multicentre Pragmatic Open-Label Randomized Controlled Trial.
Abstract Number: 1330

Clinical Presentations of Relapsing Polychondritis: More Than a Swollen Ear
Abstract Number: 209

Clinical Response of Tophus and Flares to Extended Use of Lesinurad in Combination with a Xanthine Oxidase Inhibitor in Patients with Gout
Abstract Number: 816

Clinical Response to Treatment with Belimumab and Mycophenolate Mofetil Is Associated with Decrease in B Cell, TGF-β and PDGF Signaling in Systemic Sclerosis
Abstract Number: 640

Clinical Responses and Synovial Vascularity in Obese Rheumatoid Arthritis Patients Treated with Adalimumab and Methotrexate
Abstract Number: 1603

Clinical Responses to Tocilizumab Analyzed By Serologic Status in Rheumatoid Arthritis
Abstract Number: 286

Clinical Significance and Prognostic Value of Neutrophil to Lymphocyte Ratio in Patients with Dermatomyositis
Abstract Number: 504

Clinical Significance of Multiple Autoantibody Specificities in Rheumatoid Arthritis: The Role of Anti-Citrullinated Alpha-Enolase and Anti-Interferon Inducible Protein 16 Antibodies
Abstract Number: 2812

Clinical Trial Simulation Identifies Factors for Patient Engagement in Systemic Lupus Erythematosus and Lupus Nephritis Trials By African-Americans
Abstract Number: 2637

Clinical Trials Aiming to Prevent the Development of Rheumatoid Arthritis Cannot Detect Prevention without Adequate Risk Stratification; A Trial Performed in UA-Patients As Example
Abstract Number: 2819

Clinical Utility of Anti-Aquaporin 4 Antibody Measurement in Patients with Neuropsychiatric Systemic Lupus Erythematosus with Neuromyelitis Optica Spectrum Disorder Manifestations
Abstract Number: 2826

Clinical Utility of Circulating Anti-N-Methyl-D-Aspartate Receptor Subunits NR2A/B Antibody for the Diagnosis of Neuropsychiatric Syndromes in Systemic Lupus Erythematosus and Sjogren’s Syndrome: An Updated Meta-Analysis
Abstract Number: 558

Clinical, Sonographic and Immunological Biomarkers of Ramris Progression in RA Patients in Clinical Remission: A Prospective Study with 12 Months of Follow-up
Abstract Number: 2691

Clinical, Radiological and Functional Characteristics of Clinically Significant Pulmonary Involvement in Primary SjöGren’s Syndrome
Abstract Number: 2679

Clinically Meaningful Improvement of Essdai and Esspri in Patients with Primary SjöGren’s Syndrome in Real Life: A 12-Month Longitudinal Study
Abstract Number: 1136

Clinician Training in Motivational Communication Skills: The Impact of the Language of Change Program Among Rheumatologists from Across Canada
Abstract Number: 1227

Clinician-Led Development of a Standardised Term Set for Rheumatic and Musculoskeletal Disorders Allows Easy Creation of Large-Scale ICD-10 and Snomed CT Mapped Datasets from Routinely Collected Clinical Data
Abstract Number: 257

CNS Manifestations of Patients with Muckle-Wells Syndrome
Abstract Number: 1751

Coagulation Pathway Function in Ischemia/Reperfusion Tissue Injury in Autoimmune Prone Mice
Abstract Number: 234

Coexistent Gout and Rheumatoid Arthritis: Comparison of Comorbidity, Autoantibodies, Disease Measures, and All-Cause Mortality
Abstract Number: 2950

Cogan Syndrome: Treatment and Outcome from French Nationwide Retrospective Study and Literature Review of 62 Patients
Abstract Number: 1396

Cognitive Function in Children with SLE Nephritis: A Cross-Sectional Comparison to Children with Other Glomerular Chronic Kidney Diseases
Abstract Number: 2205

Cognitive Functioning in Fibromyalgia: The Central Role of Effort
Abstract Number: 2454

Cohort of Pregnant Women with Ro/La Antibodies: Risk of Fetal Third Degree Atrioventricular Block and Use of Hydroxychloroquine
Abstract Number: 216

Colchicine Prescribing As a Parameter for QA/QI Process in Gout Care
Abstract Number: 849

Collagen Formation/Degradation Neoepitopes Are Promising Biomarkers for Systemic Sclerosis
Abstract Number: 1455

Collagen-Induced Arthritis and Uveitis in Mice Lacking TNF Receptors
Abstract Number: 1454

Combination of the SYK Inhibitor, GS-9876, with a JAK Inhibitor Increases Efficacy in a Chronic Rat Model of Collagen-Induced Arthritis
Abstract Number: 1725

Combination Therapy of Apremilast and Biologic Agent As a Safe Option of Psoriatic Arthritis and Psoriasis
Abstract Number: 1278

Combined Positron Emission Tomography and Magnetic Resonance Imaging in Assessing Gastrointestinal Involvement in Systemic Sclerosis: A Pilot Study
Abstract Number: 804

Combined-Phenotype Meta-GWAS in Systemic Sclerosis and Rheumatoid Arthritis Identifies IRF4 As a New Common Susceptibility Locus
Abstract Number: 1107

Combining Scaffold-Free Cartilage Transplants to Controlled Gene Expression for Therapeutic Application in Rheumatic Disorders
Abstract Number: 450

Coming Full Circle with the Omeract RA Flare Questionnaire (RA-FQ): Further Evaluation of the Properties, Meaningfulness, and Utility through Rasch Analysis and Feedback from RA Patients
Abstract Number: 187

Commensal Microbiota Tune Systemic Toll-like Receptor-Mediated Inflammatory Responses
Abstract Number: 1834

Commensal Ro60 Autoantigen Ortholog Cross-Reactivity in Human Lupus and Gnotobiotic Models
Abstract Number: 2565

Common Biomarker Elevations in Idiopathic Pulmonary Fibrosis and Rheumatoid Arthritis-Associated Interstitial Lung Disease
Abstract Number: 43

Comorbid Development of Fibromyalgia and Posttraumatic Stress Disorder after Exposure to a Combat Environment
Abstract Number: 2176

Comorbidities and DMARD, NSAID and Steroid Use in a Real Life Cohort of 8,981 Patients with Psoriatic Arthritis
Abstract Number: 397

Comorbidities Associated with Pediatric Psoriatic Arthritis
Abstract Number: 1550

Comorbidities of Rheumatoid Arthritis: Results from the Korean National Health and Nutrition Examination Survey
Abstract Number: 2776

Comparability of Patients Classified As Non-Radiographic Axial Spondyloarthritis By the Imaging Vs Clinical Arms of the ASAS Criteria
Abstract Number: 407

Comparability of Proxy, Adolescent and Adult Measures of Functional Ability in Adolescents with JIA
Abstract Number: 2596

Comparable Safety and Immunogenicity and Sustained Efficacy after Transition to SB2 (An Infliximab Biosimilar) Vs Ongoing Reference Infliximab (Remicade®) in Patients with Rheumatoid Arthritis: Results of Phase III Transition Study
Abstract Number: 149

Comparation of Ultrasonic Imaging of Enthesopathy in the Lower Extremity in Patients with Psoriatic Arthritis, Psoriasis and Other Inflammatory Arthritis
Abstract Number: 2809

Comparative Analysis of Anti-Nuclear Antibody Testing Using Blinded Replicate Samples Reveals Variability Between Commercial Testing Laboratories
Abstract Number: 3L

Comparative Cardiovascular Safety of Tocilizumab Vs Etanercept in Rheumatoid Arthritis: Results of a Randomized, Parallel-Group, Multicenter, Noninferiority, Phase 4 Clinical Trial
Abstract Number: 311

Comparative Effectiveness of Ayurveda and Conventional Care in Knee Osteoarthritis – a Randomized Controlled Trial
Abstract Number: 597

Comparative Effectiveness of Different Anti-TNF Drugs As First Biological DMARD in RA: Results from the Nationwide Swedish Register 2010-2015
Abstract Number: 946

Comparative Effectiveness of Second-Line Treatment Strategies for Lyme Arthritis in Children
Abstract Number: 1739

Comparative Effectiveness of Secukinumab and Adalimumab in Ankylosing Spondylitis As Assessed By Matching-Adjusted Indirect Comparison: An Analysis Based on All Pivotal Phase 3 Clinical Trial Data
Abstract Number: 1596

Comparative Effectiveness of Tocilizumab Monotherapy with Tumor Necrosis Factor Inhibitors in Combination with Methotrexate in Patients with Rheumatoid Arthritis and Prior Exposure to Tumor Necrosis Factor Inhibitors
Abstract Number: 2529

Comparative Effectiveness of Tofacitinib, Biologic Drugs and Traditional Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis
Abstract Number: 632

Comparative Improvement in Health-Related Quality of Life for RA Patients Between TNF-α Inhibitors, Other Biologics, and Tofacitinib: Results from a US-Wide Observational Study
Abstract Number: 1475

Comparative Risk of Cardiovascular Outcomes Between Topical and Oral Non-Selective Nsaids in Taiwanese Rheumatoid Arthritis Patients
Abstract Number: 1982

Comparative Safety of Long-Acting Opioids for Non-Cancer Pain
Abstract Number: 1656

Compare the Potential of Osteoclast Precursors (OCPs) Residing in Bone Marrow and Peripheral Blood As the Surrogates of Psoriasis Pathogenesis
Abstract Number: 2746

Comparing Prevalence of Comorbidities in Patients with Psoriatic Arthritis By Biologic Therapy
Abstract Number: 226

Comparing the Burden of Illness of Patients with Tophaceous and Non-Tophaceous Gout in France, Germany, Italy, Spain, UK, and USA
Abstract Number: 2083

Comparing the Electronic Patient Reported Outcome (ePro) Tool Versus the Paper Reported Outcome (pPro) Tool in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol
Abstract Number: 1472

Comparison Between Carotid Plaque and Carotid Intima-Media Thickness to Detect Subclinical Atherosclerosis in Rheumatoid Arthritis
Abstract Number: 1488

Comparison Between Carotid Ultrasonography and Coronary Artery Calcification Score to Detect Subclinical Atherosclerosis in Rheumatoid Arthritis
Abstract Number: 1487

Comparison Between Intima-Media Thickness and Coronary Artery Tomography in Subclinical Atheroesclerosis Detection in Rheumatoid Arthritis
Abstract Number: 953

Comparison of 10-Years Disease Outcomes of Rheumatoid Arthritis Patients with Continued Low Disease Activity on Methotrexate with or without Initial Combination Therapy with Infliximab or Prednisone and Sulfasalazine
Abstract Number: 442

Comparison of Adherence and Dosing Interval of Subcutaneous Anti-TNF Biologics in Inflammatory Arthritis from a Canadian Administrative Database.
Abstract Number: 1728

Comparison of Adherence to Disease Modifying Antirheumatic Drugs in Psoriatic Arthritis and Other Rheumatic Disease
Abstract Number: 2242

Comparison of Assessment and Management of RA and Other Rheumatic Diseases By Rheumatologists in Private Practices or an Academic Medical Center
Abstract Number: 507

Comparison of Body Mass Index, Anti-Citrullinated Peptides Antibodies Status and Periodontal Condition in First Degree Relatives Individuals to Rheumatoid Arthritis
Abstract Number: 2987

Comparison of Certolizumab Pegol Versus Adalimumab: 2 Year Efficacy and Safety Results from a Superiority, Investigator-Blind, Head-to-Head Study
Abstract Number: 3093

Comparison of Changes in Cardiovascular Risk-Associated Biomarkers in RA Patients Treated with Anti-TNF or Other Biological Agents: A Metabolic Study from a Randomized Trial
Abstract Number: 2803

Comparison of Clinical and Serological Differences According to the Autoantibody Cluster in Women with Systemic Lupus Erythematosus: Results from the Korean Lupus Network (KORNET) Registry
Abstract Number: 2333

Comparison of Clinical Outcomes of Total Ankle Arthroplasty Between Biologics and NON-Biologics Treatment Groups in Patients with Rheumatoid Arthritis
Abstract Number: 1289

Comparison of Clinical Parameters and PET/MRI in Juvenile Idiopathic Arthritis
Abstract Number: 2755

Comparison of Clinical Profile of Geriatric and Non-Geriatric Ankylosing Spondylitis (AS) Patients
Abstract Number: 2249

Comparison of Discontinuation Rates Among Patients with RA Initiating Biologics
Abstract Number: 2464

Comparison of Disease Activity Score (DAS) 28-CRP to DAS28-ESR in Patients with Active Rheumatoid Arthritis
Abstract Number: 32

Comparison of Effects of Leukocyte-RICH and Leukocyte-Poor Platelet-RICH Plasma on PAIN and Functionality in Patients with Lateral Epicondylitis
Abstract Number: 1220

Comparison of Healthcare Utilization of Patients with Rheumatoid Arthritis Who Are Anti-Cyclic Citrullinated Peptide Antibody Positive Versus Negative
Abstract Number: 726

Comparison of Infliximab Immunogenicity in Inflammatory Arthritis Versus Inflammatory Bowel Disease Patients in Routine Clinical Practice
Abstract Number: 2586

Comparison of Intra-Articular Methylprednisolone Acetate with Triamcinolone Acetonide in Acutely Swollen Knee Joint of Patients with Chronic Inflammatory Arthritis – a Randomized Controlled Trial
Abstract Number: 2538

Comparison of Intravenous Versus Subcutaneous Abatacept for the Treatment of Rheumatoid Arthritis in a Routine Clinical Care Setting: A Preliminary, Time to Response Analysis
Abstract Number: 2815

Comparison of Lupus Nephritis Induction Therapy with Cyclophosphamide High Dose Versus Low Dose
Abstract Number: 559

Comparison of Multi-Dimensional Health Assessment Questionnaire (MD-HAQ)-Based and Patient-Reported Outcomes Measurement Information System (PROMIS) 29-Based Routine Assessment of Patient Index 3 (RAPID3) for Assessing Rheumatoid Arthritis Disease Activity
Abstract Number: 2202

Comparison of New and Old American College of Rheumatology Classification Criterion for Diagnosis of Fibromyalgia
Abstract Number: 482

Comparison of Nonclinical Pharmacology, Pharmacodynamics and Efficacy Response of the Proposed Adalimumab Biosimilar GP2017 to Originator Adalimumab
Abstract Number: 2197

Comparison of Objectively Measured Physical Activity Among People with Symptomatic Knee Osteoarthritis with the General US Population
Abstract Number: 1371

Comparison of Patient and Physician Reported Global Disease Activity Measures in Juvenile Dermatomyositis
Abstract Number: 2953

Comparison of Patient Outcomes in Primary Angiitis of the Central Nervous System and Reversible Cerebral Vasoconstriction Syndrome
Abstract Number: 1245

Comparison of Secukinumab Vs Adalimumab in a Cost per Responder Analysis Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatment of Psoriatic Arthritis at 48 Weeks from the US Perspective
Abstract Number: 2356

Comparison of Spa Therapy with or without Physical Rehabilitation for Knee Osteoarthritis: A Randomized Controlled Trial
Abstract Number: 16L

Comparison of Systematic Vs Individually Tailored Rituximab Regimen to Maintain ANCA-Associated–Vasculitis Remission: Results of a Prospective, Randomized–Controlled, Phase 3 Trial
Abstract Number: 2689

Comparison of the 2016 ACR/EULAR and the 2002 AECG Classification Criteria in a Cohort of Patients with Suspected Primary SjöGren’s Syndrome
Abstract Number: 2802

Comparison of the Clinical, Serological, and Prognostic Differences Among Juvenile-, Adult-, and Late-Onset Lupus Nephritis in Korean Patients: A Case-Control Study
Abstract Number: 1372

Comparison of the Printo 2010 and Printo/International Myositis and Clinical Studies Group (IMACS) 2016 Improvement Criteria in the Printo Trial in New Onset Juvenile Dermatomyositis
Abstract Number: 1384

Comparison of the Systemic Lupus Collaborating Clinics-Damage Index Score with a Physician Global Assessment of Damage in an International Cohort of Patients with Childhood-Onset Systemic Lupus
Abstract Number: 949

Comparison of Treatment Response, Remission Rate and Drug Adherence in Polyarticular Juvenile Idiopathic Arthritis Patients Treated with Etanercept, Adalimumab or Tocilizumab
Abstract Number: 1929

Comparison of Two Different ANCA Iif Methods with EIA and Disease Phenotype
Abstract Number: 2589

Comparison of Two Enzyme-Linked Immunosorbent Assays Used for Drug Concentration Monitoring in Psoriatic Arthritis Patients Treated with Certolizumab Pegol
Abstract Number: 2175

Comparisons of Patients Prescribed Biosimilars or BIO-Originators for Autoimmune Diseases in Germany
Abstract Number: 2094

Complement Activation in Antiphospholipid Syndrome Due to the Multi-Activated Pathways of the Complement System
Abstract Number: 511

Complement C3 and C4 Levels and Its Correlation with Disease Activity in Rheumatoid Arthritis Patients
Abstract Number: 751

Complement C4d Split Products on Erythrocytes Are Associated with Composite Measure of Disease Activity in Systemic Lupus Erythematosus Subjects Receiving Methotrexate and Hydroxychloroquine
Abstract Number: 925

Complement C5a Receptor Is the Key Initiator of Neutrophil Adhesion and Inflammation in Immune Complex-Induced Arthritis
Abstract Number: 786

Complement Split Product iC3b and C3 Blood Levels Best Associate with Active and Clinically Meaningful Changes in SLE Disease Activity
Abstract Number: 3119

Complete Whole Genome Transcriptome, DNA Methylation, and Histone Mark Analysis of Rheumatoid Arthritis (RA) Fibroblast-like Synoviocytes (FLS) Reveals a Distinctive Epigenetic Landscape and Critical Pathogenic Pathways
Abstract Number: 1723

Composite Psoriatic Disease Activity Index (CPDAI), Defining Remission and Disease Activity States Using Data from Daily Clinical Practice
Abstract Number: 2820

Comprehensive Aptamer-Based Screening of 1129 Proteins Reveals Novel Urinary Biomarkers of Lupus Nephritis
Abstract Number: 836

Comprehensive Characterization of Calcinosis in a Multicenter International Cohort of Patients with Systemic Sclerosis
Abstract Number: 655

Comprehensive Immuno-Phenotyping of Follicular Helper T Cells and B Cell Subpopulations in Primary Sjögren’s Syndrome
Abstract Number: 3126

Computational Polarizing Microscopy: A Novel Method to Detect Birefringent Crystals Using Lens-Free on-Chip Microscopy
Abstract Number: 2195

Conceptualizing the Life Course in the Employment Experiences of Working-Aged Adults with Arthritis: A Qualitative Study
Abstract Number: 1500

Concomitant Development of Interstitial Pneumonia Associated with Dermatomyositis and Rheumatoid Arthritis
Abstract Number: 619

Concomitant Treatment Use during Treatment with Golimumab in Patients with Rheumatoid Arthritis
Abstract Number: 2516

Concomitant Use of Oral Vs. Subcutaneous Methotrexate at Biologic Initiation: A Comparison of Biologic Treatment Survival in a Rheumatoid Arthritis Cohort
Abstract Number: 2750

Concordance Between Patient and Physician Global Assessment of the Disease in Patients with Psoriatic Arthritis
Abstract Number: 2473

Concordance Between the Patient, Nurse and Physician Assessment of Clinical Outcomes in a Cohort of Rheumatoid Arthritis Patients Treated with Certolizumab Pegol
Abstract Number: 547

Concordance Between Ultrasound Joint Synovitis and Clinical Joint Assessments By Patients or Physicians in Rheumatoid Arthritis
Abstract Number: 235

Concurrence of Rheumatoid Arthritis and Calcium Pyrophosphate Deposition Disease: Description of a Cohort
Abstract Number: 2775

Conductive Hearing Loss Is Common in Ankylosing Spondylitis
Abstract Number: 1134

Confidence and Competence of Medicine Trainees’ Musculoskeletal Skills: A Report of the Relationship from a Large Multi-Year, Multidisciplinary Cohort
Abstract Number: 1877

Confirmatory Factor Analysis and Assessment of Differential Item Functioning of the Satisfaction with Appearance Scale in Systemic Sclerosis: A Comparison Across Sex, Race/Ethnicity and Disease Subtype
Abstract Number: 1630

Consistent Pharmacodynamic Effects of Sirukumab, an Anti–IL-6 Cytokine Monoclonal Antibody, on Serum Analytes Across Four Phase 3 Clinical Trials in Rheumatoid Arthritis
Abstract Number: 1704

Consistent Safety and Tolerability of Secukinumab over Long-Term Exposure in Patients with Active Psoriatic Arthritis and Moderate to Severe Plaque Psoriasis: Updated Pooled Safety Analyses
Abstract Number: 870

Contemporary Prevalence Estimates for Giant Cell Arteritis and Polymyalgia Rheumatica, 2015
Abstract Number: 3252

Content Analysis of Ergonomic Recommendations Using the Ergonomic Assessment Tool for Arthritis
Abstract Number: 2448

Contraceptive Methods in Women with Rheumatoid Arthritis
Abstract Number: 1334

Contribution of Diagnostic Investigations in the Management of Uveitis: Retrospective Analysis of 300 Patients
Abstract Number: 518

Contribution of Patient Global Assessment on Loss and Gain of Disease Remission in Patients with Established Rheumatoid Arthritis in Clinical Practice
Abstract Number: 477

Conventional Non-Steroidal Anti-Inflammatory Drugs, but Not COX2 Selective Inhibitors, Are Beneficial on Vascular Function in Arthritis: A Study in Adjuvant Induced Arthritis
Abstract Number: 2598

Conversion Rate of Tuberculosis Screening Tests in Patients with Rheumatic Diseases While Receiving Anti-Tumor Necrosis Factor Alpha (anti-TNFα) Agents
Abstract Number: 1478

Coronary Artery Calcification in Rheumatoid Arthritis Patients Is Not Characterized By an Increase in Genes Associated with Coronary Artery Disease in the General Population
Abstract Number: 3191

Coronary Revascularization Procedure Rates and Risks Among Patients with Systemic Lupus Erythematosus Compared to Those with Diabetes Mellitus in a Nationwide Medicaid Cohort
Abstract Number: 1469

Coronary Territories Are Not Affected in Mexican Mestizo Patients with Rheumatoid Arthritis in Comparison to Matched Controls: Evaluation Using Speckle Tracking Echocardiography
Abstract Number: 1548

Correlates of Fatigue in People Living with Rheumatoid Arthritis
Abstract Number: 2810

Correlates of Spontaneous Cytokine Production in Individuals Undergoing Interferon-Gamma Release Assay Testing
Abstract Number: 2485

Correlates of Successful Flare Management: The Role of Clinician-Driven Treatment, Home-Based Strategies, and Medication Change
Abstract Number: 1397

Correlation and Responsiveness of Cutaneous Lupus Disease Area and Severity Index (CLASI) and Skindex-29 with Cutaneous Childhood Lupus Erythematosus (cSLE)
Abstract Number: 343

Correlation Between Metacarpal Cortical Bone Mineral Density Measured By Dual X-Ray Densitometry and Radiogrammetry on Early Arthritis Patients
Abstract Number: 728

Correlation Between the Spinal MRI Findings and the Serum Level of DKK-1 in Patients with Spondyloarthritis Treated with TNF Antagonist
Abstract Number: 1356

Correlation of Erythrocyte Sedimentation Rate with Glycohemoglobin Values and Other Patient Factors
Abstract Number: 1011

Correlations Between B Cell Epitope Specificity and Clinical Features in Patients with Jo-1 Antibodies and the Anti-Synthetase Syndrome
Abstract Number: 326

Cortical Bone Changes in Pre- and Postmenopausal Healthy Women Measured with HR-pQCT
Abstract Number: 253

Corticosteroid-Free Tocilizumab Monotherapy for Adult Onset Still’s Disease: Results in Six Month
Abstract Number: 1515

Could Increase Levels of Dickkopf-1 Protein be Considered As a Potential Biomarker for Bone Resorption in Joint and Periodontal Disease in Patients with Early Rheumatoid Arthritis?
Abstract Number: 2435

Counseling on Family Planning and Contraception, and Pregnancy Outcome in Women with Rheumatic Diseases: Analysis of 398 Patient-Reported Questionnaires from a Multicenter Italian Study
Abstract Number: 1090

CpG-Stimulated B Cells Require Glutaminolysis for Glycolysis, Mitochondrial Respiration, and Cytokine Production
Abstract Number: 2262

CR6086 a New Potent EP4 Receptor Antagonist with Immunomodulatory Activities
Abstract Number: 1972

Creatine Kinase in the United States Population: Impact of Demographics, Comorbidities and Body Composition on the Normal Range
Abstract Number: 308

Crepitus As a Risk Factor for Symptomatic Knee Osteoarthritis: Data from the Osteoarthritis Initiative
Abstract Number: 2869

Critical Roles of IRAK4 Kinase Activity in Inflammation but Not B Cell Response in SLE
Abstract Number: 448

Cross-Cultural and Construct Validity of the Animated Activity Questionnaire to Assess Activity Limitations in Patients with Hip and Knee Osteoarthritis in Different Languages
Abstract Number: 451

Cross-Sectional and Longitudinal Construct Validity for the Improved Health Assessment Questionnaire Among Adults with Knee Osteoarthritis
Abstract Number: 2155

Crosstalk Between IL-6 and TNF-Alpha Signaling Pathway in Rheumatoid Arthritis Synovial Fibroblasts
Abstract Number: 470

Crucial Involvement of Citrullinated Proteins and ACPA in the Development of Peptide-Glucose-6-Phosphate Isomerase Induced Arthritis
Abstract Number: 2290

Crystal-Proven Gout and Disease Severity Factors Influencing the Prevalence of Cardiovascular Diseases
Abstract Number: 845

Current Use of Off-Label Therapies in Systemic Sclerosis-Associated Interstitial Lung Disease
Abstract Number: 1846

Cutaneous and Visceral Fibrosis Induced By Endothelial Cell-Specific Constitutive Activation of TGF-β1 Signaling in Mice
Abstract Number: 1934

Cutaneous Manifestations of ANCA-Associated Vasculitis
Abstract Number: 1708

Cutaneous Microbiota Features Distinguish Psoriasis from Psoriatic Arthritis
Abstract Number: 2422

Cyclic Amp, Erk5, and Transdifferentiation of Cardiac Fibroblasts in the Pathogenesis of Autoimmune Congenital Heart Block
Abstract Number: 667

Cytokine and Chemokine Levels in Serum and Saliva As Disease Activity Biomarkers in Patients with Primary Sjögren’s Syndrome
Abstract Number: 663

Cytokine and Chemokine Levels in Serum and Tears As Disease Activity Biomarkers in Patients with Primary Sjögren´s Syndrome
Abstract Number: 2126

Cytokine Dependent Effects of Anti-Inflammatory Inhibitors Targeting JAK and p38 on Cartilage Turnover
Abstract Number: 1670

Cytokine Expression in Groups of Psoriatic Arthritis Patients Characterised By Specific HLA Genotypes and Clinical Features
Abstract Number: 252

Cytokine Profiles of Korean Patients with Adult Onset Still’s Disease Treated with Biologic Agents
Abstract Number: 2116

Cytokines Inhibition Modulates Activation and Homing Receptor of Different Peripheral Memory B Cell Subsets in RA
Abstract Number: 1001

Cytomegalovirus Reactivation in Connective Tissue Disease By Immunosuppressive Therapy Predicts Severe Infection and High Mortality